• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤由两种与超级增强子相关的分化状态组成。

Neuroblastoma is composed of two super-enhancer-associated differentiation states.

机构信息

Department of Oncogenomics, Academic Medical Center, Amsterdam, the Netherlands.

Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands.

出版信息

Nat Genet. 2017 Aug;49(8):1261-1266. doi: 10.1038/ng.3899. Epub 2017 Jun 26.

DOI:10.1038/ng.3899
PMID:28650485
Abstract

Neuroblastoma and other pediatric tumors show a paucity of gene mutations, which has sparked an interest in their epigenetic regulation. Several tumor types include phenotypically divergent cells, resembling cells from different lineage development stages. It has been proposed that super-enhancer-associated transcription factor (TF) networks underlie lineage identity, but the role of these enhancers in intratumoral heterogeneity is unknown. Here we show that most neuroblastomas include two types of tumor cells with divergent gene expression profiles. Undifferentiated mesenchymal cells and committed adrenergic cells can interconvert and resemble cells from different lineage differentiation stages. ChIP-seq analysis of isogenic pairs of mesenchymal and adrenergic cells identified a distinct super-enhancer landscape and super-enhancer-associated TF network for each cell type. Expression of the mesenchymal TF PRRX1 could reprogram the super-enhancer and mRNA landscapes of adrenergic cells toward a mesenchymal state. Mesenchymal cells were more chemoresistant in vitro and were enriched in post-therapy and relapse tumors. Two super-enhancer-associated TF networks, which probably mediate lineage control in normal development, thus dominate epigenetic control of neuroblastoma and shape intratumoral heterogeneity.

摘要

神经母细胞瘤和其他儿科肿瘤表现出基因突变的缺乏,这激发了人们对其表观遗传调控的兴趣。几种肿瘤类型包括表型不同的细胞,类似于来自不同谱系发育阶段的细胞。有人提出,超级增强子相关转录因子(TF)网络是谱系身份的基础,但这些增强子在肿瘤内异质性中的作用尚不清楚。在这里,我们表明大多数神经母细胞瘤包括两种具有不同基因表达谱的肿瘤细胞。未分化的间充质细胞和有丝分裂的肾上腺素能细胞可以相互转化,并类似于来自不同谱系分化阶段的细胞。对间充质和肾上腺素能细胞的同基因对进行 ChIP-seq 分析,确定了每种细胞类型独特的超级增强子图谱和超级增强子相关 TF 网络。间充质 TF PRRX1 的表达可以重新编程肾上腺素能细胞的超级增强子和 mRNA 图谱,使其向间充质状态发展。间充质细胞在体外具有更强的耐药性,并且在治疗后和复发肿瘤中富集。两个超级增强子相关的 TF 网络,可能介导正常发育中的谱系控制,因此主导神经母细胞瘤的表观遗传控制,并塑造肿瘤内异质性。

相似文献

1
Neuroblastoma is composed of two super-enhancer-associated differentiation states.神经母细胞瘤由两种与超级增强子相关的分化状态组成。
Nat Genet. 2017 Aug;49(8):1261-1266. doi: 10.1038/ng.3899. Epub 2017 Jun 26.
2
Recent advances in the developmental origin of neuroblastoma: an overview.神经母细胞瘤发生发展的最新研究进展:综述
J Exp Clin Cancer Res. 2022 Mar 11;41(1):92. doi: 10.1186/s13046-022-02281-w.
3
Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells.超级增强子相关的核心调控回路介导神经母细胞瘤细胞对视黄酸的敏感性。
Front Cell Dev Biol. 2022 Sep 6;10:943924. doi: 10.3389/fcell.2022.943924. eCollection 2022.
4
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment.转录、表观遗传和逆转录病毒特征可识别参与造血谱系定向分化的调控区域。
Sci Rep. 2016 Apr 20;6:24724. doi: 10.1038/srep24724.
5
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.NOTCH 正向反馈环驱动神经母细胞瘤从肾上腺素能状态向间充质状态重编程。
Nat Commun. 2019 Apr 4;10(1):1530. doi: 10.1038/s41467-019-09470-w.
6
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.肿瘤坏死因子-α与表皮生长因子联合诱导SH-SY5Y神经母细胞瘤细胞发生肾上腺素能向间充质转分化。
Cancer Sci. 2021 Feb;112(2):715-724. doi: 10.1111/cas.14760. Epub 2020 Dec 21.
7
Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation.谱系特异性转录因子波将神经母细胞瘤从自我更新重编程为分化。
Nat Commun. 2024 Apr 23;15(1):3432. doi: 10.1038/s41467-024-47166-y.
8
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.神经母细胞瘤细胞身份的异质性由转录电路定义。
Nat Genet. 2017 Sep;49(9):1408-1413. doi: 10.1038/ng.3921. Epub 2017 Jul 24.
9
Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis.造血过程中增强子文库的动态控制驱动谱系和阶段特异性转录
Dev Cell. 2016 Jan 11;36(1):9-23. doi: 10.1016/j.devcel.2015.12.014.
10
Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice.先驱因子在干细胞可塑性和谱系选择中调控超级增强子动力学。
Nature. 2015 May 21;521(7552):366-70. doi: 10.1038/nature14289. Epub 2015 Mar 18.

引用本文的文献

1
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticity.RBM39降解剂可增强先天免疫以根除神经母细胞瘤,尽管癌细胞具有可塑性。
Nat Commun. 2025 Sep 17;16(1):8287. doi: 10.1038/s41467-025-63979-x.
2
Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma.靶向铁死亡诱导增强化疗耐药性神经母细胞瘤的化疗疗效。
NPJ Precis Oncol. 2025 Sep 16;9(1):311. doi: 10.1038/s41698-025-01090-6.
3
Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma.

本文引用的文献

1
Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma.单细胞RNA测序支持人类少突胶质细胞瘤的发育层次结构。
Nature. 2016 Nov 10;539(7628):309-313. doi: 10.1038/nature20123. Epub 2016 Nov 2.
2
Multi-organ Mapping of Cancer Risk.癌症风险的多器官图谱
Cell. 2016 Aug 25;166(5):1132-1146.e7. doi: 10.1016/j.cell.2016.07.045.
3
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.通过单细胞RNA测序剖析转移性黑色素瘤的多细胞生态系统
神经节苷脂谱分析揭示高危神经母细胞瘤的不同模式。
Int J Mol Sci. 2025 Aug 29;26(17):8431. doi: 10.3390/ijms26178431.
4
Three-Dimensional Culture Systems in Neuroblastoma Research.神经母细胞瘤研究中的三维培养系统
Organoids. 2025 Jun;4(2). doi: 10.3390/organoids4020010. Epub 2025 May 8.
5
diaPASEF-Powered Chemoproteomics Enables Deep Kinome Interaction Profiling.基于diaPASEF的化学蛋白质组学实现深度激酶组相互作用图谱分析。
J Proteome Res. 2025 Aug 27. doi: 10.1021/acs.jproteome.5c00109.
6
PLK4 as a Key Regulator of Neuroblastoma Differentiation and a Promising Therapeutic Target.PLK4作为神经母细胞瘤分化的关键调节因子及一个有前景的治疗靶点。
Int J Biol Sci. 2025 Jul 28;21(11):4979-4996. doi: 10.7150/ijbs.111449. eCollection 2025.
7
High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas.高内涵成像药物协同筛选确定了间充质神经母细胞瘤特定的衰老相关脆弱性。
Cell Death Dis. 2025 Aug 25;16(1):644. doi: 10.1038/s41419-025-07933-1.
8
Cell state plasticity in neuroblastoma.神经母细胞瘤中的细胞状态可塑性
EJC Paediatr Oncol. 2024 Dec;4. doi: 10.1016/j.ejcped.2024.100184. Epub 2024 Aug 2.
9
Integrative analysis of CRISPR screening and gene expression data identifies a three-gene prognostic model associated with immune microenvironment in neuroblastoma.CRISPR筛选与基因表达数据的综合分析确定了一种与神经母细胞瘤免疫微环境相关的三基因预后模型。
Transl Cancer Res. 2025 Jul 30;14(7):4058-4070. doi: 10.21037/tcr-2024-2472. Epub 2025 Jul 14.
10
Regulation and dysregulation of microRNA - transcription factor axes in differentiation and neuroblastoma.微小RNA-转录因子轴在分化和神经母细胞瘤中的调控与失调
Cell Mol Life Sci. 2025 Aug 8;82(1):304. doi: 10.1007/s00018-025-05832-4.
Science. 2016 Apr 8;352(6282):189-96. doi: 10.1126/science.aad0501.
4
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.由LMO1超级增强子多态性介导的神经母细胞瘤遗传易感性。
Nature. 2015 Dec 17;528(7582):418-21. doi: 10.1038/nature15540. Epub 2015 Nov 11.
5
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium.测序质量控制联盟对RNA测序准确性、可重复性和信息含量的全面评估。
Nat Biotechnol. 2014 Sep;32(9):903-14. doi: 10.1038/nbt.2957. Epub 2014 Aug 24.
6
Improved vectors and genome-wide libraries for CRISPR screening.用于CRISPR筛选的改良载体和全基因组文库。
Nat Methods. 2014 Aug;11(8):783-784. doi: 10.1038/nmeth.3047.
7
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.单细胞 RNA 测序凸显原发性脑胶质瘤肿瘤内异质性。
Science. 2014 Jun 20;344(6190):1396-401. doi: 10.1126/science.1254257. Epub 2014 Jun 12.
8
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.重建和重编程神经胶质瘤干细胞的肿瘤增殖潜能。
Cell. 2014 Apr 24;157(3):580-94. doi: 10.1016/j.cell.2014.02.030. Epub 2014 Apr 10.
9
An atlas of active enhancers across human cell types and tissues.人类细胞类型和组织中活跃增强子图谱。
Nature. 2014 Mar 27;507(7493):455-461. doi: 10.1038/nature12787.
10
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours.无血清培养基中增殖的新衍生神经母细胞瘤细胞系重现了原发神经母细胞瘤肿瘤的基因型和表型。
Eur J Cancer. 2014 Feb;50(3):628-37. doi: 10.1016/j.ejca.2013.11.015. Epub 2013 Dec 6.